A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma.

Cumulative information available about the organization of amplified chromosomal regions in human tumors suggests that the amplification repeat units, or amplicons, can be of a simple or complex nature. For the former, amplified regions generally retain their native chromosomal configuration and involve a single amplification target sequence. For complex amplicons, amplified DNAs usually undergo substantial reorganization relative to the normal chromosomal regions from which they evolve, and the regions subject to amplification may contain multiple target sequences. Previous efforts to characterize the 7p11.2 epidermal growth factor receptor ) amplicon in glioblastoma have relied primarily on the use of markers positioned by linkage analysis and/or radiation hybrid mapping, both of which are known to have the potential for being inaccurate when attempting to order loci over relatively short (<1 Mb) chromosomal regions. Due to the limited resolution of genetic maps that have been established through the use of these approaches, we have constructed a 2-Mb bacterial and P1-derived artificial chromosome (BAC-PAC) contig for the EGFR region and have applied markers positioned on its associated physical map to the analysis of 7p11.2 amplifications in a series of glioblastomas. Our data indicate that EGFR is the sole amplification target within the mapped region, although there are several additional 7p11.2 genes that can be coamplified and overexpressed with EGFR. Furthermore, these results are consistent with EGFR amplicons retaining the same organization as the native chromosome 7p11.2 region from which they are derived.

[1]  David I. Smith,et al.  3′ End structure and rearrangements of EGFR in glioblastomas , 1998, Genes, chromosomes & cancer.

[2]  K. Ichimura,et al.  Chromosome 7 rearrangements in glioblastomas; loci adjacent to EGFR are independently amplified. , 1998, Journal of neuropathology and experimental neurology.

[3]  P. Humphrey,et al.  Structural alterations of the epidermal growth factor receptor gene in human gliomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Marynen,et al.  Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults , 1998, Oncogene.

[6]  C. James,et al.  Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Murphy,et al.  Structure and organization of amplified DNA on double minutes containing the mdm2 oncogene. , 1993, Genomics.

[8]  C. James,et al.  Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms. , 2001, Genomics.

[9]  P. Meltzer,et al.  Twelve amplified and expressed genes localized in a single domain in glioma , 1996, Human Genetics.

[10]  Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements. , 2000, Neuro-oncology.

[11]  C. James,et al.  GBAS, a novel gene encoding a protein with tyrosine phosphorylation sites and a transmembrane domain, is co-amplified with EGFR. , 1998, Genomics.

[12]  Anne Jedlicka,et al.  Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells , 2001, Acta Neuropathologica.

[13]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[14]  David I. Smith,et al.  Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences , 1998, Oncogene.

[15]  J. Todd,et al.  Framework YAC contig anchored into a 3.2-Mb high-resolution physical map in proximal 11q13. , 1997, Genomics.

[16]  R. Wilson,et al.  High throughput fingerprint analysis of large-insert clones. , 1997, Genome research.

[17]  M. Schwab,et al.  The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma , 1996, Genes, chromosomes & cancer.

[18]  K. Tadokoro,et al.  Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas. , 1994, Nucleic acids research.

[19]  G. Brodeur,et al.  MYCN Is the only highly expressed gene from the core amplified domain in human neuroblastomas , 1998, Genes, chromosomes & cancer.

[20]  S. Weissman,et al.  cDNA selection: efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Church,et al.  Transcript mapping of the human chromosome 11q12-q13.1 gene-rich region identifies several newly described conserved genes. , 1998, Genomics.

[22]  S. S. Schneider,et al.  High-resolution mapping of the N-myc amplicon core domain in neuroblastomas. , 1994, Progress in clinical and biological research.

[23]  C. Manohar,et al.  Co‐amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma , 1995, Genes, chromosomes & cancer.

[24]  E. Mardis,et al.  Generation and analysis of 280,000 human expressed sequence tags. , 1996, Genome research.

[25]  N. Tsuchida,et al.  Defining a common region of DNA amplification at 22q11.2–12 in head and neck squamous cell carcinomas by quantitative FISH analysis , 2000, Genes, chromosomes & cancer.

[26]  J W Gray,et al.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Michael L. Bittner,et al.  Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Couch,et al.  Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. , 2001, Cancer research.

[29]  C. Theillet,et al.  17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification , 1999, Oncogene.

[30]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[31]  J. Cowell,et al.  Double minutes and homogeneously staining regions: gene amplification in mammalian cells. , 1982, Annual review of genetics.

[32]  T. Matsunaga,et al.  Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus , 1996, Genes, chromosomes & cancer.

[33]  A. Marchler-Bauer,et al.  Characterization of p40/GPR69A as a peripheral membrane protein related to the lantibiotic synthetase component C. , 2000, Biochemical and biophysical research communications.

[34]  M. Bittner,et al.  Molecular cytogenetic characterization and physical mapping of 12q13–15 amplification in human cancers , 1996, Genes, chromosomes & cancer.

[35]  K. Ichimura,et al.  The Complexity of the 7p12 Amplicon in Human Astrocytic Gliomas: Detailed Mapping of 246 Tumors , 2000, Journal of neuropathology and experimental neurology.

[36]  P. Green,et al.  Analysis of expressed sequence tags indicates 35,000 human genes , 2000, Nature Genetics.

[37]  G. Brodeur,et al.  High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. , 1996, Genomics.

[38]  S. Knuutila,et al.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.